Cargando…
Characterizing SARS-CoV-2 Viral Clearance Kinetics to Improve the Design of Antiviral Pharmacometric Studies
A consensus methodology for the pharmacometric assessment of candidate SARS-CoV-2 antiviral drugs would be useful for comparing trial results and improving trial design. The time to viral clearance, assessed by serial qPCR of nasopharyngeal swab samples, has been the most widely reported measure of...
Autores principales: | Watson, James A., Kissler, Stephen M., Day, Nicholas P. J., Grad, Yonatan H., White, Nicholas J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295592/ https://www.ncbi.nlm.nih.gov/pubmed/35736134 http://dx.doi.org/10.1128/aac.00192-22 |
Ejemplares similares
-
2301. Viral Kinetics of Sequential SARS-CoV-2 Infections
por: Kissler, Stephen, et al.
Publicado: (2023) -
Viral kinetics of sequential SARS-CoV-2 infections
por: Kissler, Stephen M., et al.
Publicado: (2023) -
Pharmacometric and Electrocardiographic Evaluation of Chloroquine and Azithromycin in Healthy Volunteers
por: Chotsiri, Palang, et al.
Publicado: (2022) -
Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period
por: Kissler, Stephen M., et al.
Publicado: (2020) -
Increased Induction Infliximab Clearance Predicts Early Antidrug Antibody Detection
por: Eser, Alexander, et al.
Publicado: (2020)